UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review article: linaclotide for the management of irritable bowel syndrome with constipation

Alimentary pharmacology & therapeutics, 2014-02, Vol.39 (4), p.371-384

2014

Volltextzugriff (PDF)

Chronic intestinal pseudo‐obstruction in children and adults: diagnosis and therapeutic options

Neurogastroenterology and motility, 2017-01, Vol.29 (1), p.np-n/a

2017

Volltextzugriff (PDF)

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators

Gut, 2009-02, Vol.58 (2), p.196-201

2009

Volltextzugriff (PDF)

Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome

The American journal of gastroenterology, 2013-09, Vol.108 (9), p.1508-1515

2013

Volltextzugriff (PDF)

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

Alimentary pharmacology & therapeutics, 2012-04, Vol.35 (7), p.745-767

2012

Volltextzugriff (PDF)

Diagnosis and treatment of chronic constipation – a European perspective

Neurogastroenterology and motility, 2011-08, Vol.23 (8), p.697-710

2011

Volltextzugriff (PDF)

Effect of prucalopride on symptoms of chronic constipation

Neurogastroenterology and motility, 2014-01, Vol.26 (1), p.21-27

2014

Volltextzugriff (PDF)

Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome

Alimentary Pharmacology & Therapeutics (Suppl), 2017-04, Vol.45 (7), p.909-922

2017

Volltextzugriff (PDF)

Three-Month Prevalence Rates of Gastrointestinal Symptoms and the Influence of Demographic Factors: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)

Scandinavian journal of gastroenterology, 1999, Vol.34 (231), p.20-28

Stanghellini, V.

1999

Volltextzugriff (PDF)

Review article: adherence to Rome criteria in therapeutic trials in functional dyspepsia

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.435-466

2014

Volltextzugriff (PDF)

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study

Alimentary pharmacology & therapeutics, 2009-08, Vol.30 (3), p.245-252

2009

Volltextzugriff (PDF)

New pathophysiological mechanisms in irritable bowel syndrome

Alimentary pharmacology & therapeutics, 2004-07, Vol.20 (s2), p.1-9

2004

Volltextzugriff (PDF)

Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction

Gut, 2004-11, Vol.53 (11), p.1549-1552

2004

Volltextzugriff (PDF)

Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (1), p.141-150

2003

Volltextzugriff (PDF)

Development and Psychometric Evaluation of the Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM) in Patients with upper Gastrointestinal Disorders

Quality of life research, 2004-12, Vol.13 (10), p.1737-1749

2004

Volltextzugriff (PDF)

Functional gastrointestinal disorders and mast cells: implications for therapy

Neurogastroenterology and motility, 2006-01, Vol.18 (1), p.6-17

2006

Volltextzugriff (PDF)

Prevalence and Socioeconomic Impact of Upper Gastrointestinal Disorders in the United States: Results of the US Upper Gastrointestinal Study

Clinical gastroenterology and hepatology, 2005-06, Vol.3 (6), p.543-552

2005

Volltextzugriff (PDF)

Review article: molecular, pathological and therapeutic features of human enteric neuropathies

Alimentary pharmacology & therapeutics, 2008-07, Vol.28 (1), p.25-42

2008

Volltextzugriff (PDF)

Chronic intestinal pseudo‐obstruction: manifestations, natural history and management

Neurogastroenterology and motility, 2007-06, Vol.19 (6), p.440-452

2007

Volltextzugriff (PDF)

A role for inflammation in irritable bowel syndrome?

Gut, 2002-07, Vol.51 (suppl 1), p.i41-44

2002

Volltextzugriff (PDF)

Comparison between small bowel manometric patterns and full‐thickness biopsy histopathology in severe intestinal dysmotility

Neurogastroenterology and motility, 2018-03, Vol.30 (3), p.n/a

2018

Volltextzugriff (PDF)

Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators

Neurogastroenterology and motility, 2018-08, Vol.30 (8), p.e13388-n/a

2018

Volltextzugriff (PDF)

Functional gastroduodenal disorders

Gut, 1999-09, Vol.45 (suppl 2), p.II37-ii42

1999

Volltextzugriff (PDF)

Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea

European review for medical and pharmacological sciences, 2017-02, Vol.21 (4), p.873

2017

Volltextzugriff (PDF)

Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons

Neurogastroenterology and motility, 2012-12, Vol.24 (12), p.1118-e570

2012

Volltextzugriff (PDF)

1 – 25 von 366

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(338)
Mit Volltextzugriff
(285)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(212)
Humans
(198)
Life Sciences & Biomedicine
(192)
Gastroenterology & Hepatology
(132)
Male
(118)
Female
(111)
Adult
(96)
Biological And Medical Sciences
(96)
Middle Aged
(89)
Medical Sciences
(88)
Aged
(48)
Pharmacology & Pharmacy
(43)
Gastroenterology. Liver. Pancreas. Abdomen
(40)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(33)
Other Diseases. Semiology
(32)
Pharmacology. Drug Treatments
(31)
Digestive System
(27)
Animals
(26)
Gastroenterology And Hepatology
(24)
Neurosciences
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Review article: linaclotide for the management of irritable bowel syndrome with constipation

Chronic intestinal pseudo‐obstruction in children and adults: diagnosis and therapeutic options

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators

Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome

Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders

Diagnosis and treatment of chronic constipation – a European perspective

Effect of prucalopride on symptoms of chronic constipation

Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome

Three-Month Prevalence Rates of Gastrointestinal Symptoms and the Influence of Demographic Factors: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)

Review article: adherence to Rome criteria in therapeutic trials in functional dyspepsia

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study

New pathophysiological mechanisms in irritable bowel syndrome

Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction

Development and validation of a patient‐assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index

Development and Psychometric Evaluation of the Patient Assessment of Upper Gastrointestinal Symptom Severity Index (PAGI-SYM) in Patients with upper Gastrointestinal Disorders

Functional gastrointestinal disorders and mast cells: implications for therapy

Prevalence and Socioeconomic Impact of Upper Gastrointestinal Disorders in the United States: Results of the US Upper Gastrointestinal Study

Review article: molecular, pathological and therapeutic features of human enteric neuropathies

Chronic intestinal pseudo‐obstruction: manifestations, natural history and management

A role for inflammation in irritable bowel syndrome?

Comparison between small bowel manometric patterns and full‐thickness biopsy histopathology in severe intestinal dysmotility

Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators

Functional gastroduodenal disorders

Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea

Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons

Suchergebnisse filtern